DRIO 0.92 (-11.54%)
US23725P2092Medical Diagnostics & ResearchDiagnostics & Research

DarioHealth (DRIO) Competitor Comparison

We are evaluating the key criteria listed to compare DarioHealth (DRIO) against its competitors in the Diagnostics & Research industry.

Linearity 3 years - DRIO ranking 46 / 58

These are the competitors of DarioHealth in the industry Diagnostics & Research ranked by linearity 3 years
1. Danaher DHR
110.42
2. Quest Diagnostics DGX
79.36
3. IQVIA Holdings IQV
63.69
4. Mettler-Toledo MTD
34.71
5. Ortho Clinical Diagnostics Holdings OCDX
33.4
6. Laboratory Corp of America Holdings LH
22.44
7. Agilent Technologies A
17.46
8. Qiagen QGEN
16.37
9. PerkinElmer PKI
16.14
10. Waters WAT
13.82
11. Thermo Fisher Scientific TMO
13.44
12. Syneos Health SYNH
10.68
13. Anixa Biosciences ANIX
8.86
14. Natera NTRA
8.44
15. Trinity Biotech TRIB
7.86
16. Heska HSKA
7.67
17. Myriad Genetics MYGN
6.82
18. Olink Holding OLK
6.67
19. Icon ICLR
5.71
20. IDEXX Laboratories IDXX
5.57
21. DexCom DXCM
5.29
22. Sotera Health SHC
4.42
23. Global Cord Blood CO
4.22
24. Exact Sciences EXAS
3.96
25. Charles River Laboratories CRL
3.91
26. National Research NRC
3.83
27. Psychemedics PMD
3.2
28. Enzo Biochem ENZ
3.13
29. Sera Prognostics SERA
3.07
30. Neogen NEOG
2.71
31. Bioventus BVS
2.63
32. RadNet RDNT
2.55
33. Twist Bioscience TWST
2.27
34. NeoGenomics NEO
2.23
35. Illumina ILMN
2.2
36. Guardant Health GH
2.16
37. MDxHealth MDXH
2.15
38. Exagen XGN
2.13
39. Fulgent Genetics FLGT
2.12
40. Inotiv NOTV
2.1
41. MaxCyte MXCT
2.05
42. Neuronetics STIM
2.04
43. Prenetics Global PRE
1.87
44. Co-Diagnostics CODX
1.84
45. Organovo Holdings ONVO
1.79
46. DarioHealth DRIO
1.79
47. bioAffinity Technologies BIAF
1.77
48. CareDx CDNA
1.77
49. Interpace Biosciences IDXG
1.75
50. Pacific Biosciences of California PACB
1.68
51. Biodesix BDSX
1.64
52. Personalis PSNL
1.61
53. Precipio PRPO
1.58
54. SeqLL SQL
1.47
55. Medpace Holdings MEDP
1.39
56. Aspira Womens Health AWH
1.38
57. Lantheus Holdings LNTH
0.79
58. Meridian Bioscience VIVO
0.73

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.